The Naga Hospital Authority Kohima (NHAK) has decided to cancel the Pharmaceutical trading license of a pharmacy on charge of selling certain brand of expired drugs.
At a meeting with the Angami Youth Organisation (AYO), an apex youth body in the state capital, certain brands of expired medicines were detected as being sold to in-patient of NHAK by the pharmacy, which is being run within the hospital premises by a private party.
The NHAK authorities also pledged to extend medical and related cover up insurances to any patient afflicted with drug related reactions arising out of the medication from such medicines, an AYO statement said.
Also Read
The AYO further urged members of the medical fraternity to carefully cross check the manufactured and expiry dates of all medicines before administering any medicines to their patients.
It has also requested the general public to be cautious on such matters.
This is largely due to lifestyle changes where a
high calorie diet is coupled with sedentary habits. Importantly, the expanding dimension of this disease emphasizes the urgent need for more sensitive methods for detection, and also for more effective regimens for treatment.
The DDRC-RBPL collaboration will focus on addressing these needs through two separate programs. The goal of one of these programs is to develop a data-based software package that will not only identify individuals/youth who are becoming susceptible to diabetes, but also predict the future course of disease in those who are already diabetic. It is anticipated that the advance warning provided by such a system will allow the target individuals to pre-emptively make the appropriate lifestyle alterations so as to mitigate disease development, and prevent its progression. The second program is to develop a new drug that will prevent re-absorption of glucose in the kidneys. This re-absorption process contributes to maintaining the high glycemic levels in diabetics. Inhibition of this process by an effective drug therefore will lead to a significant lowering of the blood glucose level.
Source: Drug Discovery Research Centre of the Translational Health Science & Technology
Institute
Parul Vaid, pvaid@imprimispr.
